Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for treatment-resistant depression
NCT00231959Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2003
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Pramipexole with Placebo (2 arms). Primary endpoints: Montgomery-Asberg Depression Rating Scale and Clinical Global Impressions scale. Started Sep 2003; status: completed.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00231959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231959.